Clinical Trial

Intratissue Electrolysis (EPI) is Effective in Deactivating Myofascial Trigger Points (MTrPs). (EPIEMG)

Study acronym: EPIEMG
Completed
View on ClinicalTrials.gov →
Summary
Invasive physiotherapy techniques, such as Intratissue Percutaneous Electroly-sis (IPE), have numerous beneficial effects depending on the pathology being treated, in-cluding the deactivation of myofascial trigger points (MTP) caused by myofascial pain syndrome (MPS). The objectives are (1) evaluate the effectiveness of low intesity IPE treatment com-pared to DN on the shortening of FHB in patients with MPS, in 4 and 12 weeks evaluation, (2) assess the distribution of plantar pressures after the interventions and (3) evaluate the modification of FHB activation following the interventions.
Trial Details
NCT Number NCT07351331
Lead Sponsor Camilo Jose Cela University
Conditions Myofascial Pain Syndrome (MPS)
Enrollment 40 participants
Start Date 2024-11-15
Primary Completion 2025-02-28 (estimated)
Study Completion 2025-04-24 (estimated)
Updated on ClinicalTrials.gov 2026-01-20